Genprex to Focus Its Clinical Efforts on Oncoprex™ in Combination Therapy with Osimertinib for Non-Small Cell Lung Cancer (NSCLC)
Austin, TX & Cambridge, MA – Feburary 5, 2020- Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today provides a clinical update and focus for its Oncoprex™ immunogene therapy program for 2020, prioritizing the development of Oncoprex […]
Top U.S. Senator Calls for Threat Detection Technology to Thwart Potential Transit Attacks
Palm Beach, FL – February 5, 2020 — There’s a groundswell of interest for threat detection technology. At Super Bowl LIV, inside and outside the Hard Rock Stadium, U.S. Customers and Border Protection used X-Ray technology to scan every vehicle coming in and going out. Other major parks are using covert threat technology, too. Oriole […]
5G Network Infrastructure Market Could Reach $4.2 Billion This Year
Palm Beach, FL – February 5, 2020 – A recent report from industry insider Gartner said the worldwide market will spike in value as businesses gear up in preparation of 5G rollouts. The report said that: “The global 5G market is expected to rise in value to $4.2 billion by the end of 2020 as […]
R&D Leading to Supported Progress For Treating Acute Myeloid Leukemia (AML)
Palm Beach, FL –February 5, 2020 – Acute Myeloid Leukemia (AML) research has seen great progress with more researchers are now studying the causes, diagnosis, and treatment of Acute myeloid leukemia (AML) at many medical centers, university hospitals, and other institutions. Acute myeloid leukemia (AML) is the second most common type of leukemia diagnosed in […]
Hawkeye Systems’ Future Subsidiary Assists with First-Ever 5G Broadcast of a Major Sports Event, the 2020 Pro Bowl
Radiant Images captures Pro Bowl streamed live in 8K into 360-degree immersive projection dome over 5G Network Los Angeles, CA – February 5, 2020 – Hawkeye Systems, Inc. (OTCQB: HWKE) announces that future subsidiary Radiant Images assisted in an 8K live stream of the 2020 NFL Pro Bowl into projection domes through a 5G […]
Moleculin to Seek Accelerated FDA Approval and Plans for Pivotal Phase 2 AML Trial
Following Successful Completion of US Phase 1 Trial Houston, TX – February 5, 2020 — Moleculin Biotech, Inc., (NASDAQ: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced it intends to discuss with the FDA and EMA (European Medicines Agency) […]
